Medicine and Dentistry
Patient
71%
Estrogen Receptor Positive Breast Cancer
43%
Breast Cancer
41%
Prognosis
34%
Biological Marker
31%
Estrogen Receptor
29%
Diet and Cancer
29%
Breast Cancer Survival
29%
Therapeutic Procedure
17%
Association
15%
Overall Survival
12%
Mortality
9%
Cancer Growth
9%
Lymph Node
7%
Lipid
7%
Protein
7%
Diethylstilbestrol
7%
Enzymes
7%
In Vitro
7%
Follow up
7%
Cancer Therapy
7%
Adjuvant Therapy
7%
Cancer Cell
7%
Proportional Hazards Model
5%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Malignant Neoplasm
74%
Recurrent Disease
46%
Atorvastatin
37%
Prognosis
32%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
31%
Fatty Acid
29%
Endocrine Therapy
11%
Neoplasm
9%
Cohort Study
5%
Estrogens
5%
Biochemistry, Genetics and Molecular Biology
Statin
48%
Atorvastatin
35%
Lipid Droplet
31%
Fatty Acid Metabolism
29%
Cholesterol Metabolism
29%
27-Hydroxycholesterol
25%
Cholesterol
23%
Lipid
19%
Unsaturated Fatty Acid
9%
Triglyceride
9%
Protein
9%
Cell Growth
9%
Enzyme
9%
Messenger RNA
7%
Reduction (Chemistry)
7%
In Vitro Study
7%
Estradiol
7%
Gene Expression Profiling
6%
Lipid Metabolism
6%
Dose
6%